DIARREST RF
देश: आयरलैंड
भाषा: अंग्रेज़ी
स्रोत: HPRA (Health Products Regulatory Authority)
उत्पाद विशेषताएं
(SPC)
03-05-2024
इस उत्पाद के लिए कुछ दस्तावेज़ वर्तमान में उपलब्ध नहीं हैं, आप हमारी ग्राहक सेवा को अनुरोध भेज सकते हैं और जैसे ही हम उन्हें प्राप्त करने में सक्षम होंगे, हम आपको सूचित करेंगे।
अनुरोध भेजा।
अनुरोध भेजा।
सक्रिय संघटक:
LOPERAMIDE HYDROCHLORIDE POTASSIUM CHLORIDE SODIUM CHLORIDE SODIUM CITRATE
थमां उपलब्ध:
Galen Limited
डोज़:
1/40/50/50 MG/5ml
फार्मास्यूटिकल फॉर्म:
Oral Solution
प्राधिकरण की तारीख:
1998-11-27
उत्पाद विशेषताएं
PART II
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Diarrest Oral Solution
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE INGREDIENTS:
Each 5ml contains:
EQUIVALENT TO APPROXIMATELY:
For excipients see 6.1.
3 PHARMACEUTICAL FORM
Oral Solution
Straw coloured liquid with a cream soda/orange odour.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Adults:
As an adjunct in the management of acute diarrhoea together with appropriate fluid and electrolyte replacement.
In the symptomatic control of diarrhoea associated with chronic inflammatory bowel disease, e.g. Crohn's disease
and ulcerative colitis; as an adjunct to specific measures such as corticosteroids and sulphasalazine. Use in these
conditions should be under specialist supervision.
In the adjunctive short-term control of post surgical diarrhoea, including ileostomy.
Children:
For the occasional use in the control of intractable diarrhoea under specialist supervision. Since persistent
diarrhoea may be an indicator of a potentially serious condition, the underlying cause must always be investigated.
4.2 POSOLOGY AND METHOD OF ADMINSTRATION
For oral administration.
Loperamide hydrochloride
1.0
mg
Potassium chloride
40.0
mg
Sodium chloride
50.0
mg
Sodium citrate
50.0
mg
Potassium
0.5
mmol/5 ml
Sodium
1.4
mmol/5 ml
Chloride
1.4
mmol/5 ml
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 20/06/2006_
_CRN 2024590_
_page number: 1_
Diarrest Oral Solution administration should be accompanied by an adequate daily fluid intake.
If no improvement in the condition of the patient is seen within two days of commencing treatment then further
investigation into the underlying cause of the diarrhoea should be performed.
ADULTS, THE ELDERLY AND CHILDREN OVER 12
पूरा दस्तावेज़ पढ़ें
